Autism and ADHD services within the NHS are facing a critical tipping point as spiraling costs and an influx of unregulated private providers threaten to destabilize care for millions. NHS leaders and health managers warn that the current patchwork system, driven by soaring demand and a policy allowing patients to choose private or NHS providers, is creating chaos rather than relief. This crisis exposes deep structural flaws in how neurodevelopmental conditions are assessed and treated, with implications for patients, families, and the public purse.
Uncontrolled Costs Undermine Sustainability of ADHD and Autism Care
One of the most alarming aspects of the current situation is the explosive growth in spending on ADHD and autism assessments and treatments. NHS Alliance data reveals some local health boards have seen costs multiply tenfold in just one year, with monthly bills reaching as high as £1.5 million. Over a two-year period, annual expenditure in some areas ballooned from £4 million to £30 million. These figures starkly contrast with other NHS services, such as hip or knee replacements, where fixed tariffs keep spending predictable and transparent.
Unlike these standardised procedures, autism and ADHD services lack set pricing, relying instead on non-binding guide prices. This absence of regulation has allowed private and charitable providers to charge widely varying fees for similar services — in one case, fees ranged from £300 to £3,000 for comparable assessments. Without a cap or enforced standards, local NHS budgets are under intense pressure, forcing difficult choices between meeting demand and controlling public spending.
Proliferation of Providers Complicates Quality Assurance
The NHS’s “right to choose” policy, designed to reduce long waiting times by allowing patients to access both NHS and non-NHS providers, has unintentionally fueled a rapid and largely unregulated expansion of service providers. Some integrated care boards now work with nearly 50 different providers, quadrupling the number from just two years ago.
While this diversification has helped some patients avoid lengthy waits, it has created a regulatory nightmare. Many private providers offering assessments are not required to register with the Care Quality Commission (CQC), the body responsible for ensuring healthcare quality and safety. This regulatory gap means NHS managers struggle to verify the competence, reliability, and safety of the growing number of providers, raising concerns about inconsistent care standards and patient safety.
Systemic Failures Reflect Years of Underinvestment
Experts and advocacy groups attribute the current chaos to chronic underfunding and lack of strategic planning for neurodevelopmental services over many years. The National Autistic Society highlights that the rising expenditure is largely funneled into short-term fixes rather than sustainable improvements.
Long waiting lists, sometimes stretching into years, have driven patients and families to seek alternatives outside the NHS, inadvertently empowering private providers to capitalize on urgent demand. This cycle has entrenched inequalities, where those with financial means can access quicker assessments and support, while others remain trapped in delays.
Government Promises a New National Approach
In response to mounting concerns, the government has committed to publishing an independent review of autism and ADHD services imminently, promising a “new national approach” to address systemic issues. This review is expected to focus on standardizing pricing, enhancing regulation of private providers, and improving overall service quality and accessibility.
However, NHS leaders warn that without swift and decisive action, the current trajectory risks pushing the system into complete disarray. The NHS Alliance describes the status quo as a “bad deal” for both patients and taxpayers, emphasizing the urgent need for coherent policy solutions that balance cost control with timely, high-quality care.
What the Future Holds for Patients and the NHS
The unfolding crisis in ADHD and autism services underscores a broader challenge facing the NHS: how to deliver specialized, complex care amid rising demand and constrained budgets. The current model, relying heavily on market-driven private provision without robust oversight, has proven unsustainable.
For patients and families, the stakes are profound. Delays in diagnosis and support can have lifelong consequences on education, employment, and mental health outcomes. For the NHS, unchecked spending threatens to divert resources from other critical areas, amplifying systemic pressures.
Addressing this crisis will require more than just incremental fixes. It demands a strategic overhaul that includes:
- Implementing regulated tariffs to bring transparency and control to pricing
- Strengthening oversight and registration requirements for all providers
- Investing in expanding NHS capacity to reduce reliance on private providers
- Developing integrated care pathways that ensure continuity and quality
As the government’s review approaches, the hope is that these measures will emerge to restore stability and fairness to ADHD and autism services, ensuring that patients receive timely, effective care without bankrupting the system.
Recommended reading
For more context, see related Peack News coverage and explainers linked below.